entertainment -WSS

entertainment

author：explore 2025-09-29 00:39:25 - browse：85525

After earning her doctorate in cell biology at the University of Pennsylvania in June, Sierra Collins did what many freshly minted Ph.D.s. do — she went looking for a job at a biotech company. But what was supposed to be a straightforward search has turned into an odyssey.

Collins has applied for more than 53 positions (and counting). Like a good scientist, she’s gathering data along the way and uses a spreadsheet to track each company’s size and therapeutic focus, as well as whether she was referred for the position and how far she made it through the application process. So far, those efforts have been unsuccessful.

“I try my best not to take it personally. These are companies that are trying to find an employee who’s going to help them achieve their business goals,” Collins said. “But it is pretty discouraging just repeatedly getting turned down, especially at later stages of the interview process.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Ascension's ugly legal battle over care for poor patients in Texas

knowledge

focus

WSS

What causes an itch? Researchers may have solved the mystery

Why sickle cell disease is getting the first CRISPR treatment

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Medicare Advantage coverage denials need scrutiny, senators say

Ascension's ugly legal battle over care for poor patients in Texas

Gene therapy denied for Afghan refugee whose father aided U.S.

Wikipedia

entertainment

knowledge

Virginia high school admissions case could be legal follow

Male doctors called my cancer incurable. A female doctor showed it wasn't

Medical leaders decry Supreme Court decision on affirmative action

JPM pitch from hospitals? Revenue streams outside of patient care

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck to acquire Harpoon Therapeutics for $680 million

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA needs staff influx to meet gene therapy needs, Marks says

Alkermes shareholders re

Pharma patents targeted by Biden in move to slash drug prices

Wikipedia

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

At JPM 2024, hospital systems pitch financial strength to investors

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Americans' trust in science, scientist continues decline: Report

In diabetes hearing, Sanders takes on a new foe: food makers

Physician assistants need a new name. Here's what it should be

knowledge

hotspot

focus

focus